A Meta-Analysis-Based Risk Score for Predicting Radiation Pneumonitis After Thoracic Radiation Therapy for Lung Cancer.

In 30 seconds

This meta-analysis developed and validated a risk score for predicting radiation pneumonitis (RP) in lung cancer patients undergoing thoracic radiation therapy. The study included three Asian cohorts, with the final score incorporating seven variables. The model achieved an area under the curve of 0.831 in the calibration cohort, with a cut-off of 53.5 points for risk stratification.

Key findings

• The final risk score included 7 variables, with a total possible score of 107.
• The model demonstrated an area under the curve of 0.831 in the calibration cohort.
• At the optimal cut-off of 53.5 points, the high-risk group had relative risks for RP of 7.270, 5.143, and 5.884.
• The scoring system is available as a web-based calculator for clinical use.

Why it matters

Accurate prediction of radiation pneumonitis is crucial for optimizing treatment plans and resource allocation in lung cancer patients. This risk score can enhance personalized management strategies.